Dana Farber Cancer Institute Boston, MA - 02215

Dana Farber Cancer Institute is categorized under Medical Research in Boston, MA and active since 1947.

Dana Farber Cancer Institute was established in 1947, and today employs 1 to 4, earning $100.000.000 to $499.999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 6223100 by the NAICS.

If you are seeking more information, feel free to contact Marianne Tawa, Manager at the company’s branch by writing to 450 Brookline Avenue, Boston, Massachusetts MA 02215 or by phoning (617) 632-3000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Dana Farber Cancer Institute
Contact Person: Marianne Tawa, Manager
Address: 450 Brookline Avenue, Boston, Massachusetts 02215
Phone Number: (617) 632-3000
Website Address: dana-farber.org
Annual Revenue (USD): $100.000.000 to $499.999.999
Founded: 1947
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Medical Research
SIC Code: 8733
NAICS Code: 6223100
Share This Business:

Dana Farber Cancer Institute was started in 1947 to provide professional Medical Research under the SIC code 8733 and NAICS code 6223100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000.000 to $499.999.999 per annum.

Feel free to contact Marianne Tawa, Manager for inquiries that concern Dana Farber Cancer Institute by calling the company number (617) 632-3000, as your correspondence is most welcome. Additionally, the physical location of the branch of Dana Farber Cancer Institute can be found at the coordinates 42.337963,-71.108251 as well as the street address 450 Brookline Avenue in Boston, Massachusetts 02215.

For its online presence, you may visit Dana Farber Cancer Institute’s website at dana-farber.org and engage with its social media outlets through on Twitter and on Facebook.